10-Q: Ultralife Corp. Q1 2026 Results Show Revenue Decline

Ultralife Corporation reported a 6.5% decrease in revenue for the first quarter of 2026 compared to the prior year, driven by declines in both commercial and government/defense sales.

Summary

• Ultralife Corporation reported a net loss of $451,000 for the first quarter of 2026, a significant shift from a net income of $1,865,000 in the same period last year.
• Consolidated revenues decreased by 6.5% to $47,445,000 for the quarter ended March 31, 2026, compared to $50,746,000 for the quarter ended March 31, 2025.
• This revenue decline was attributed to a 5.5% decrease in commercial sales and an 8.2% decrease in government/defense sales.
• Gross profit margin decreased to 21.3% from 25.1% year-over-year, impacted by sales product mix, higher utility costs, and production delays.
• Operating expenses increased by 10.5% to $10,325,000, driven by higher R&D costs for new product development and non-recurring expenses related to consulting and litigation.
• Adjusted EBITDA was $3,209,000 for Q1 2026, down from $5,448,000 in Q1 2025.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a negative filing due to the significant decline in revenue, profitability, and the persistence of a material weakness in internal controls, despite some positive investments in R&D and future capital raising flexibility.

Positives

• The company continues to invest in new product development, with R&D costs increasing by 23.2% to support future growth opportunities.
• Refundable tax credits under the 45X Advanced Manufacturing Production Credit provided a positive impact on other income.
• The company has significant U.S. net operating loss carryforwards available to offset future taxable income.
• Management expects positive operating cash flow and sufficient availability under its Revolving Credit Facility to meet funding requirements.

Negatives

• Net loss attributable to Ultralife Corporation was $451,000 for Q1 2026, compared to a net income of $1,865,000 in Q1 2025.
• Consolidated revenues decreased by 6.5% to $47,445,000 in Q1 2026.
• Gross profit margin declined to 21.3% from 25.1% in the prior year's quarter.
• Operating expenses increased by 10.5% to $10,325,000, impacting profitability.
• Adjusted EBITDA decreased to $3,209,000 from $5,448,000 year-over-year.
• A material weakness in internal control over financial reporting persists, related to accounting expertise and IT general controls.

Risks

• Uncertain global economic conditions, including inflation, tariffs, interest rates, and supply chain disruptions.
• Reliance on certain key customers for a significant portion of revenues.
• Reductions or delays in U.S. and foreign military spending.
• Potential disruptions or delays in the supply of raw materials and components, or material increases in their costs.
• Safety risks associated with the manufacture, use, and transportation of Lithium batteries.
• Variability in quarterly and annual results and the price of common stock.
• Rising interest rates increasing the cost of variable borrowings.
• Inability to comply with changes to regulations for product shipment.
• Potential costs attributable to product warranties.
• Negative publicity concerning Lithium-ion batteries.
• Exposure to foreign currency fluctuations.
• Potential impairments of goodwill and other intangible assets.
• Known and unknown environmental matters.
• Exposure to possible violations of anti-corruption laws.

Future Outlook

The company expects positive operating cash flow and sufficient availability under its Revolving Credit Facility to meet its general funding requirements for the foreseeable future. Management is focused on improving manufacturing efficiencies, driving Communications Systems orders, and executing backlog replenishment to restore profitability and generate incremental cash flow for 2026. Proceeds from potential future sales under the shelf registration statement may be used for general corporate purposes, including acquisitions, strategic capital expenditures, and product development.

Management Comments

• We remain intently focused on improving manufacturing efficiencies at our Newark, NY facility, particularly as we ramp up production of new products, in order to increase the gross margin of Battery & Energy Products, and on driving Communications Systems orders.
• These improvements, along with execution and replenishment of our backlog, position Ultralife to restore profitability and generate incremental cash flow for 2026 to reduce debt, support strategic capital expenditures, continue our investment in new product development and maximize the value of our global brand.
• Management has concluded that our disclosure control and procedures were not effective as of March 31, 2026, because of the existing material weakness in our internal control over financial reporting.

Industry Context

StockSavvy.ai notes that Ultralife Corporation's Q1 2026 results reflect challenges common in the battery and communications systems sectors, including supply chain pressures, rising costs, and shifts in demand from both commercial and defense clients. The company's strategic rebranding and focus on operational efficiencies are key initiatives to navigate these industry headwinds.

Comparison to Industry Standards

• The decline in gross margin to 21.3% for Ultralife Corporation in Q1 2026 is below the typical gross margins seen in the specialized battery manufacturing sector, which can range from 30% to 50% for companies focused on high-margin niche products.
• The reported operating loss of 0.5% of revenue is a concern when compared to industry leaders in advanced battery technologies who often maintain operating margins in the mid-to-high teens.
• Ultralife's revenue decline of 6.5% in Q1 2026 contrasts with some competitors in the energy storage sector who have reported growth driven by demand for electric vehicles and renewable energy solutions, though defense-related revenue can be more cyclical.
• The company's R&D investment of 23.2% of operating expenses is a positive sign, aligning with industry best practices where significant investment in innovation is crucial for maintaining a competitive edge in rapidly evolving battery and communication technologies.

Corporate Governance

Legal Proceedings

• Litigation expenses incurred for cyber-insurance claim.

Stakeholder Impact

• Shareholders: Potential negative impact on share price due to reduced profitability and ongoing control weaknesses. Positive aspect is the continued investment in R&D and flexibility for future capital raises.
• Employees: The material weakness in internal controls could create uncertainty. Continued investment in R&D may lead to new product development opportunities.
• Creditors: The company's focus on improving cash flow and reducing debt is positive. Compliance with debt covenants is maintained.
• Suppliers: Potential impact from reduced sales volume, though the company is focused on improving operational efficiencies.

Next Steps

• Continue to improve manufacturing efficiencies at the Newark, NY facility.
• Drive Communications Systems orders.
• Execute backlog replenishment.
• Restore profitability and generate incremental cash flow for 2026.
• Reduce debt.
• Support strategic capital expenditures.
• Continue investment in new product development.
• Maximize the value of the global brand.
• Implement corrective actions to remediate identified ITGC deficiencies and complete remediation of internal control over financial reporting.

Key Dates

Recommendation

While the Q1 2026 results show a significant downturn in revenue and profitability, the company is actively investing in R&D and has a clear strategy to improve operations. The persistence of material weaknesses in internal controls is a concern, but the company's ability to maintain debt covenants and its flexibility for future capital raises suggest a 'hold' recommendation. Investors should monitor the remediation progress of internal controls and the execution of the operational improvement plan.

Keywords

Ultralife Corporation, Form 10-Q, Quarterly Report, Financial Results, Revenue, Net Loss, Gross Profit, Operating Expenses, Adjusted EBITDA, Battery & Energy Products, Communications Systems, SEC Filing